No Data
No Data
Windtree Announces Partnership With New Growth Advisors To Leverage Phase 2 Istaroxime Study In Cardiogenic Shock For A Potential Strategic Transaction
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Sector Update: Health Care Stocks Mixed Wednesday Afternoon
Windtree Therapeutics Engages Strategic Adviser to Evaluate Options for Cardiovascular Portfolio; Shares Fall
Express News | Windtree Therapeutics Inc - May Receive up to $138 Million in Milestones From Lee's Pharmaceuticals
Express News | Windtree Therapeutics Inc - Lee's Pharmaceuticals to Start Phase 3 in Acute Heart Failure in H1 2025
No Data
No Data